• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Talanta . Highly accurate and sensitive diagnostic detection of SARS-CoV-2 by digital PCR

tetano

Editor, Senior Moderator
Talanta


. 2021 Mar 1;224:121726.
doi: 10.1016/j.talanta.2020.121726. Epub 2020 Oct 27.
Highly accurate and sensitive diagnostic detection of SARS-CoV-2 by digital PCR


Lianhua Dong[SUP] 1 [/SUP], Junbo Zhou[SUP] 2 [/SUP], Chunyan Niu[SUP] 1 [/SUP], Quanyi Wang[SUP] 3 [/SUP], Yang Pan[SUP] 3 [/SUP], Sitong Sheng[SUP] 4 [/SUP], Xia Wang[SUP] 1 [/SUP], Yongzhuo Zhang[SUP] 1 [/SUP], Jiayi Yang[SUP] 1 [/SUP], Manqing Liu[SUP] 2 [/SUP], Yang Zhao[SUP] 1 [/SUP], Xiaoying Zhang[SUP] 4 [/SUP], Tao Zhu[SUP] 5 [/SUP], Tao Peng[SUP] 1 [/SUP], Jie Xie[SUP] 1 [/SUP], Yunhua Gao[SUP] 1 [/SUP], Di Wang[SUP] 1 [/SUP], Xinhua Dai[SUP] 6 [/SUP], Xiang Fang[SUP] 7 [/SUP]



Affiliations
Free PMC article

Abstract

The outbreak of COVID-19 caused by a novel Coronavirus (termed SARS-CoV-2) has spread to over 210 countries around the world. Currently, reverse transcription quantitative qPCR (RT-qPCR) is used as the gold standard for diagnosis of SARS-CoV-2. However, the sensitivity of RT-qPCR assays of pharyngeal swab samples are reported to vary from 30% to 60%. More accurate and sensitive methods are urgently needed to support the quality assurance of the RT-qPCR or as an alternative diagnostic approach. A reverse transcription digital PCR (RT-dPCR) method was established and evaluated. To explore the feasibility of RT-dPCR in diagnostic of SARS-CoV-2, a total of 196 clinical pharyngeal swab samples from 103 suspected patients, 77 close contacts and 16 supposed convalescents were analyzed by RT-qPCR and then measured by the proposed RT-dPCR. For the 103 fever suspected patients, 19 (19/25) negative and 42 (42/49) equivocal tested by RT-qPCR were positive according to RT-dPCR. The sensitivity of SARS-CoV-2 detection was significantly improved from 28.2% by RT-qPCR to 87.4% by RT-dPCR. For 29 close contacts (confirmed by additional sample and clinical follow up), 16 (16/17) equivocal and 1 negative tested by RT-qPCR were positive according to RT-dPCR, which is implying that the RT-qPCR is missing a lot of asymptomatic patients. The overall sensitivity, specificity and diagnostic accuracy of RT-dPCR were 91%, 100% and 93%, respectively. RT-dPCR is highly accurate method and suitable for detection of pharyngeal swab samples from COVID-19 suspected patients and patients under isolation and observation who may not be exhibiting clinical symptoms.

Keywords: Coronavirus disease (COVID-19); Novel coronavirus (termed SARS-CoV-2); Reverse transcription digital PCR (RT-dPCR); Reverse transcription quantitative qPCR (RT-qPCR); Sensitivity.
 
Back
Top Bottom